ZECUITY (nda202278)- (EQ 6.5MG BASE/4HR)

Generic Name	SUMATRIPTAN SUCCINATE	Innovator	TEVA BRANDED PHARM
Dosage	EQ 6.5MG BASE/4HR
ParaIV Filing	No	505(b)2 Filing	Yes
Last Patent Expiry	2032-Oct-08	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	ZECUITY is a serotonin (5HT) 1b/1d receptor agonist (triptan) indicated for the acute treatment of migraine with or without aura in adults.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
EQ 6.5MG BASE/4HR	**	**	-	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	0

Manufacturing Details of ZECUITY